How Big Will Japan’s Nutritional Supplements Market
Introduction to Japan's Nutritional Supplements Market:
Japan's dietary supplements industry has become one of the most advanced and innovation-led industries in the world. It is at the nexus of science, culture, and consumer health awareness. The Japan nutritional supplements market size reached USD 28.40 Billion in 2024, and looking forward, the market is expected to reach USD 53.80 Billion by 2033, exhibiting a CAGR of 6.60% during 2025–2033. Japanese consumers have traditionally adopted the ethic of preventive health, where balance and energy through diet take precedence over medical intervention for reaction. This is a deeply ingrained cultural psyche that has established dietary supplements as part of mainstream life and not a fad.
The contemporary Japanese consumer regards supplements as part of a well-rounded diet and a tool to enhance mental alertness, physical performance, and lifespan. The market caters to a broad range of products from vitamins and minerals to probiotics, herbal preparations, amino acids, and beauty-from-within products. The products are frequently formulated with precision, supported by clinical observations and quality control that mirror Japan's emphasis on perfection and reliability in health-related products.
The emergence of an aging population, changing lifestyle trends, and increasing interest in individualized health are revolutionizing the nutritional supplement market. Japanese firms have now started combining traditional nutrients with advanced biotechnology to offer natural yet effective supplements. Building on this platform, the nation's market keeps growing with a consistent approach to innovation coupled with a healthy-conscious culture that prioritizes long-term health over quick fixes.
Explore in-depth findings for this market, Request Sample
Current Market Environment and Consumer Health Trends:
Japan’s nutritional supplements market is evolving at the intersection of technology, culture, and lifestyle. Japanese consumers are highly discerning, favoring clean, transparent, and evidence-based products from trusted brands. With rising health awareness, demand has shifted from general wellness supplements to personalized solutions targeting immunity, digestion, cognitive health, skin vitality, and energy balance. The industry also reflects a unique blend of food and pharmaceutical sciences, where functional foods and nutraceuticals converge into innovative forms like gummies, beverages, and powders, offering both convenience and proven efficacy.
Digitalization has further redefined consumer engagement, with e-commerce platforms, online health communities, and subscription models driving growth. According to sources, Japanese consumers are increasingly embracing personalized nutrition services offered through digital platforms, reflecting a broader shift toward tech-enabled wellness engagement. Personalization powered by wearable technology and data analytics enables tailored supplement recommendations. Simultaneously, growing awareness of holistic wellness is pushing consumers toward plant-based, sustainable, and ethically sourced ingredients. This focus on transparency and eco-conscious choices highlights a cultural shift toward mindful consumption, where individual health, environmental responsibility, and collective well-being are deeply interconnected in Japan’s evolving health ecosystem.
Key Factors Driving Market Growth in Japan:
Japan’s nutritional supplements market is expanding steadily, driven by multiple demographic and lifestyle factors. The most significant driver is the country’s rapidly aging population, which has heightened demand for supplements that support vitality, joint health, cardiovascular function, and cognitive performance. Products aimed at maintaining mobility and mental acuity among older adults have become increasingly mainstream as longevity and quality of life take center stage.
At the same time, younger consumers are also fueling market growth through a growing interest in preventive health. With fast-paced urban lifestyles and mounting work-related stress, many are turning to supplements to maintain balance and well-being. In January 2025, Kaneka Corporation launched a new supplement, “Susumu Chikara Kinniku-Care Shukan Support,” formulated with lemon myrtle extract to promote muscle health—reflecting how Japanese firms are blending scientific innovation with natural ingredients to meet evolving wellness needs. The Japanese concept of “pursuing wellness prior to illness” resonates strongly with this demographic, fostering a culture of proactive health management that cuts across all age groups.
Innovation in formulation and ingredient sourcing further strengthens the market. Companies are using advanced biotechnologies, nanotechnology, and fermentation processes to boost bioavailability and absorption. Traditional Japanese ingredients such as green tea extracts, seaweed minerals, and probiotics from miso or natto are being reimagined through modern science, resulting in natural, multifunctional, and evidence-based supplements that appeal to both domestic and global consumers seeking Japan’s hallmark of quality and innovation. In fact, Japan is increasingly being recognised as a centre of fermentation and microbiota research, as shown by the decision to host the global “First Conjoint Meeting ISM-RIKEN – Targeting Microbiota” in Tokyo in October 2025.
Government Regulations and Quality Standards for Supplements:
Japan’s regulation of nutritional supplements is among the most stringent and structured globally, emphasizing consumer protection, transparency, and accurate labeling. Supplements are categorized under Foods with Health Claims (FHC), which include subgroups based on the strength of scientific evidence supporting their efficacy and safety. Manufacturers must comply with strict Good Manufacturing Practices (GMP), ensuring purity, consistency, and ingredient accuracy from sourcing to packaging. Many companies go beyond legal requirements by obtaining voluntary third-party certifications, reinforcing their commitment to quality assurance and consumer trust.
This strong focus on scientific validation has driven significant investment in clinical research and ingredient innovation, giving Japan’s supplement market a global reputation for reliability and credibility. However, the 2024 incident involving Kobayashi Pharmaceutical—where red yeast rice (beni koji) supplements were recalled after reports of kidney-related health issues, leading to executive resignations—highlighted how seriously regulatory agencies and manufacturers address safety lapses, reaffirming Japan’s commitment to consumer protection. The government’s initiatives in promoting nutritional literacy and balanced diets further complement this regulatory framework, encouraging informed consumption and healthier lifestyles. Together, these factors create a well-regulated and health-conscious environment where quality, science, and innovation sustain the industry’s long-term growth and global competitiveness.
Market Size Forecast and Growth Projections to 2033:
Japan’s nutritional supplements market is projected to maintain steady growth through 2033, driven by demographic change, technological progress, and evolving consumer lifestyles. High health literacy and consistent consumption patterns provide a strong domestic base, while innovations in product categories and delivery systems continue to stimulate market expansion. The country’s aging population and increasing urban pace are reinforcing the demand for convenient health solutions that align with modern living.
As technology and nutrition converge, personalized healthcare is set to become more accessible. Consumers will increasingly rely on AI-driven tools and digital health platforms to monitor nutrient levels and receive real-time product recommendations. Companies that invest in data analytics, artificial intelligence, and digital engagement will gain a competitive advantage by offering customized supplement experiences tailored to Japan’s tech-savvy population.
Another defining trend is the premiumization of supplements. Japanese consumers are prioritizing products with proven efficacy, transparent sourcing, and elegant packaging that reflect brand integrity. This focus on quality and design enhances Japan’s global reputation for purity and innovation, attracting international consumers. With rising exports and expanding global distribution, Japan’s supplement market is poised for continued robust growth through 2033, powered by innovation, trust, and enduring brand value.
.webp)
Future Opportunities and Emerging Product Segments:
Japan’s nutritional supplement market is entering a new phase of innovation and diversification, with personalized nutrition emerging as a major growth driver. Advances in genomics and microbiome research are enabling companies to design supplements tailored to individual biological profiles. Through DNA-based recommendations and gut health analysis, brands are developing customized formulations that improve nutrient absorption and overall wellness. This scientific approach reflects Japan’s focus on precision and health optimization, positioning the market at the forefront of personalized healthcare.
Another promising segment lies in beauty and mental wellness supplements. Japan’s cultural connection between health and aesthetics has spurred strong demand for “beauty from within” products such as collagen, hyaluronic acid, and antioxidant blends that promote skin vitality. At the same time, mental wellness supplements formulated with natural adaptogens, nootropics, and amino acids are gaining momentum as consumers seek support for stress relief and cognitive performance. These products resonate deeply with Japan’s holistic approach to well-being, emphasizing harmony between mind and body.
Sustainability and innovation are further shaping the market’s evolution. Plant-based and vegan supplements made from algae, fermented plants, and marine-free omega sources are appealing to eco-conscious consumers, while food technology is driving new formats like fortified beverages, functional snacks, and dissolvable sticks that fit seamlessly into busy lifestyles. As the market continues to evolve, brands that combine authenticity, transparency, and scientific credibility will thrive. Those leveraging Japan’s heritage of craftsmanship and innovation to create effective, sustainable, and culturally resonant health solutions will define the next generation of the country’s supplement industry.
Conclusion:
Japan's supplements market reflects the country's unique combination of tradition, innovation, and dedication to wellness. Its roots in preventive medicine and quality control remain the driving factors behind consumer trust and global respect. As the market continues to progress toward 2033, it will be marked by growing personalization, premiumization, and sustainability. From next-generation biotech products to botanical breakthroughs, the industry will continue to adapt to changing lifestyles and health concerns.
What most sets Japan's nutritional supplement market apart is that it is a balance between contemporary science and ancient wisdom. This harmony ensures that expansion will be in market size, but also in the lasting value that it adds to consumers who are looking for wellness that lasts for a lifetime. Japan's nutritional supplements industry has a bright future that as active and resilient as the society that supports it, reaffirming itself as a world leader in health innovation and consumer confidence.
Choose IMARC for Comprehensive Analysis of Japan’s Nutritional Supplements Market:
For authoritative, data-driven intelligence on Japan’s nutritional supplements industry, IMARC Group is the trusted research partner providing actionable insights that guide strategic growth, innovation, and investment across this dynamic and health-conscious market.
- Extensive Market Coverage: IMARC’s analysis encompasses the full range of supplement categories including vitamins, minerals, probiotics, amino acids, herbal extracts, and functional foods, while also exploring emerging frontiers such as personalized nutrition, clean-label products, and plant-based formulations, ensuring a holistic view of the industry landscape.
- Reliable Forecasting and Strategic Outlook: Utilizing advanced forecasting tools, our reports integrate demographic trends, evolving health behaviors, regulatory developments, and technological innovations to deliver accurate projections supporting product development, brand expansion, and long-term investment planning.
- In-Depth Competitive Landscape: IMARC provides detailed assessments of leading supplement manufacturers, pharmaceutical companies, and emerging nutraceutical startups. Our evaluation covers their R&D priorities, product pipelines, marketing strategies, and market share dynamics, helping clients benchmark performance and refine their competitive positioning.
- Regulatory and Consumer Insights: Our comprehensive analysis of Japan’s “Foods with Health Claims” regulatory framework and consumer segmentation by age, lifestyle, and health goals offers actionable clarity for compliance, product positioning, and market entry strategies.
- Innovation and Policy Intelligence: IMARC tracks government policies promoting healthy aging, preventive healthcare, and functional food innovation, highlighting initiatives that drive demand and foster collaboration between academia, research institutions, and private enterprises.
- Trusted Global Expertise: With a reputation for analytical depth and precision, IMARC continues to empower global clients with comprehensive intelligence, enabling them to navigate Japan’s supplement ecosystem confidently and capitalize on emerging opportunities in one of the world’s most advanced nutrition markets.
Our Clients
Contact Us
Have a question or need assistance?
Please complete the form with your inquiry or reach out to us at
Phone Number
+91-120-433-0800+1-201-971-6302
+44-753-714-6104
Previous Post
A syringe is a medical instrument that is used to inject fluids into the body or to withdraw fluids from the body. A syringe usually has a cylindrical body, a plunger that moves inside the body to generate pressure or suction, and a nozzle to which a needle can be attached.
Cosmetic surgery in Australia today has evolved into a significant element of the greater beauty and wellness economy. Changing cultural attitudes, advances in medical aesthetics, and the rise of social media over the last ten years have reconstituted the ways in which cosmetic surgery is perceived and undertaken by Australians.
The contact lenses market represents a dynamic segment of the global vision care industry, characterized by continuous innovation and expanding demographic demand.
Brazil's diagnostic imaging equipment market stands at a pivotal moment as Latin America's largest and most dynamic healthcare arena. With substantial investments in hospital modernization, regulatory reforms, and artificial intelligence adoption, the market is transforming rapidly. As providers transition from analog to AI-ready platforms, Brazil emerges as a critical destination for medical device manufacturers seeking growth through the next decade.
The Indian healthcare space has indeed been changing. Telemedicine has emerged as one of the most important drivers of this change. Driving this transformation is the increased adoption of digital tools, growing patient awareness, and the pressing need to make healthcare more accessible across diverse geographies.
The Australia medical aesthetics industry size reached USD 396.4 Million in 2025. Looking forward, the market is expected to reach USD 784.8 Million by 2034, exhibiting a growth rate (CAGR) of 7.89% during 2026-2034. Over the last ten years, the medical aesthetic industry in Australia has transformed from a niche beauty service into a mainstream part of healthcare and wellness.
A rapid diagnostic test (RDT) kit is a medical device designed to quickly detect specific biomarkers, antigens, antibodies, or nucleic acids linked to diseases—typically within minutes and without the need for sophisticated laboratory equipment. These kits often use lateral flow assays, immunochromatographic strips, or rapid molecular testing methods to deliver fast and reliable results.
The Philippines pharmaceutical industry stands as one of Southeast Asia's most dynamic and rapidly expanding healthcare markets in the ASEAN region. With a market valuation reaching USD 3.36 Billion in 2025, the sector demonstrates resilience and tremendous growth potential.
Pharmaceuticals are medical products, substances, or formulations involved in the development, manufacture, and regulation for the prevention, diagnosis, treatment, and management of diseases in humans as well as animals.
The Australia aged care industry stands at a pivotal juncture as the nation grapples with demographic shifts that are reshaping the landscape of elderly care services. With an aging population that continues to expand, Australia faces both unprecedented challenges and remarkable opportunities in delivering quality care to its senior citizens.
The Indian vaccines industry holds an unparalleled position globally, often celebrated as the pharmacy of the world due and its massive production scale and capabilities. It reached INR 113.7 Billion in 2024 according to IMARC Group and it is projected to grow at a CAGR of 8.8% from 2025-2033.
The medical imaging market has reached a transformational phase, driven both by rapid technological advancements and growing demands for precision-driven diagnostics. As health systems worldwide come under increasing pressure to improve patient outcomes while minimizing procedural risks and optimizing clinical workflows, medical imaging has become one of the most important cornerstones of modern medicine.
India’s medical devices industry is on a sustained growth trajectory driven by expanding hospital infrastructure, rising chronic disease burden, stronger local manufacturing supported by government incentives, and a rapidly growing shift toward portable and home care devices.
Pectin represents a naturally occurring polysaccharide mainly extracted from cell walls of fruits (mainly from citrus peel and apple pomace). It is a soluble dietary fiber and a hydrocolloid with gelling, thickening, and stabilizing properties. It is mostly composed of galacturonic acid units.
Paracetamol, also referred to as acetaminophen, is an analgesic and antipyretic compound that is commonly used worldwide for the treatment of mild to moderate pain and the management of fever. The mechanism of action occurs mainly in the central nervous system, where it inhibits the mechanisms that regulate pain and body temperature, but lacks anti-inflammatory properties.
The Australia wellness tourism industry has emerged as a critical segment of the country’s broader travel and hospitality sector. It reflects a growing global emphasis on health, self-care, and holistic well-being, capturing the attention of travelers seeking experiences that combine relaxation, rejuvenation, and personal growth.
The Brazil cardiovascular devices market represents a crucial segment in the country’s healthcare ecosystem, addressing one of the leading causes of morbidity and mortality: cardiovascular diseases. Conditions such as heart attacks, stroke, arrhythmias, and heart failure require ongoing medical intervention and advanced heart disease treatment solutions. With the rising prevalence of cardiovascular disorders, demand for comprehensive cardiac care equipment and innovative treatment modalities is increasing.
India's Ayurvedic products market is experiencing remarkable transformation as consumers increasingly prioritize holistic wellness and natural remedies over conventional alternatives. The convergence of traditional healing wisdom with modern consumer preferences has created a dynamic landscape where herbal medicines, chemical-free personal care products, and immunity-boosting supplements are becoming household staples.
Nicotine pouches are small, smokeless oral delivery products of nicotine, free from tobacco, designed to allow for controlled release of the active principle without burning, vaporizing, or use of traditional tobacco leaves. It consists of a small pouch that contains a matrix made basically from plant fibers, flavorings, pH adjusters, and stabilizers impregnated with nicotine, encased in a permeable material permitting the gradual absorption of the product via the oral mucosa.
The pharmaceutical industry in Japan is among the most advanced globally, recognized for combining innovation, high-quality standards, and patient-centered care. Its extensive value chain includes drug discovery, clinical trials, manufacturing, distribution, marketing, and post-market surveillance. Serving both domestic and international markets, Japanese pharmaceutical companies are respected for regulatory compliance, safety, and reliability, establishing them as trusted global collaborators in drug development.
The pharmaceutical industry in Japan is among the most advanced globally, recognized for combining innovation, high-quality standards, and patient-centered care. Its extensive value chain includes drug discovery, clinical trials, manufacturing, distribution, marketing, and post-market surveillance. Serving both domestic and international markets, Japanese pharmaceutical companies are respected for regulatory compliance, safety, and reliability, establishing them as trusted global collaborators in drug development.
The global healthcare IT industry is on a remarkable upswing, fueled by the surge in preventive care, digital health platforms, and smarter patient management systems. According to IMARC Group, the market hit USD 363.15 Billion in 2024, a clear sign of worldwide adoption. An aging population, the growing comfort with remote care, and the push toward personalized medicine are all speeding this momentum.
The global endoscopy devices market is on a sharp growth path, fueled by the shift toward minimally invasive procedures, the need for early diagnosis, and cutting-edge imaging technologies. IMARC Group reported the market hit USD 50.01 Billion in 2024, underscoring its worldwide acceptance.
The global business-to-business (B2B) payments landscape is experiencing a fundamental transformation that is reshaping how enterprises conduct financial transactions across borders and industries. The market, valued at approximately 1,189.6 Billion in 2024, is projecting remarkable growth with expectations to reach USD 2,189.0 Billion by 2033, exhibiting a CAGR of 7% from 2025-2033. This exponential expansion is signaling a paradigm shift in commercial finance, driven by technological innovation, changing business expectations, and the urgent need for more efficient payment infrastructures.
The smart medical devices market is entering a decade defined by connected care, real-time diagnostics, and patient empowerment. Valued at USD 45.9 Billion in 2024, the market is projected to reach USD 82 Billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.33% between 2025 and 2033 by IMARC Group. This steady rise reflects growing confidence in data-driven healthcare systems, integration of IoT in medical environments, and the increasing role of artificial intelligence in clinical decision-making.
Active Pharmaceutical Ingredients (APIs) are the bioactive molecules of any drug used in pharmaceuticals, which cause the desired therapeutic action in the body of a human being. APIs are the central core of all drugs, chemical or biological and are responsible for the efficacy, strength, and safety of the drug. APIs are synthesized by various complex chemical synthesis, fermentation, biotechnological, or extraction processes based on the type of drug.
A bio medical incinerator is a high-temperature combustion system specialized for biomedical waste disposal by hospitals, clinics, laboratories, and research institutions. Biomedical waste usually consists of infectious waste, pathological waste, sharps, pharmaceuticals, and contaminated disposables that are very hazardous to human health and the environment if not treated.
Obesity, once viewed primarily as a lifestyle choice, is now widely recognized as a complex and chronic disease characterized by excessive body fat accumulation. Its global prevalence is escalating at an alarming rate posing a significant and growing challenge to public health systems worldwide.
Gonorrhea, a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae, is a major public health issue globally. Reports show that over one million new cases of curable STIs are contracted every day by individuals aged 15 to 49 years, with the majority being asymptomatic.
The 7 major allergic conjunctivitis markets reached a value of USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 2.9 Billion by 2035, exhibiting a growth rate (CAGR) of 3.00% during 2025-2035.
The healthcare sector is changing rapidly because of the growing demand for better ways to manage chronic diseases. As we move toward 2025 and beyond, digital tools are playing an important role in dealing with conditions like diabetes, heart disease, cancer, and respiratory problems.
The global multivitamin gummies market consists of chewable dietary supplements that are charged with key vitamins and minerals aimed at maintaining general health and wellness. The gummies present a handy, enjoyable, and easy-to-swallow option to classic pills or tablets, hence are predominantly preferred by children and adults who do not like taking pills.
India's pharmaceutical sector is evolving rapidly, supported by the integration of artificial intelligence (AI) across the value chain. As of 2023, India ranked as the third-largest pharmaceutical producer by volume, accounting for 20% of global generic drug exports.
As Lung Cancer Awareness continues to build global momentum in 2025, Artificial Intelligence (AI) is proving to be a transformative force—not only in clinical diagnostics but also in public education and preventive health efforts. Given that lung cancer remains one of the world’s deadliest cancers, accounting for over 1.8 million deaths each year and a five-year survival rate of just 28.4%, the integration of AI marks a critical turning point.
Observed on May 19, Hepatitis Testing Day 2025 emphasizes the need to "Test. Treat. Eliminate," highlighting the gap in diagnosing hepatitis B and C, which cause over 1.3 million deaths annually. Hepatitis remains a major global health threat, on par with HIV, tuberculosis, and malaria. The growing viral hepatitis market <Viral Hepatitis Market Size | Share, Trends - 2034 > reflects rising demand for better diagnostics, treatments, and integrated care. The WHO warns that without faster testing and treatment, the goal of eliminating hepatitis by 2030 may not be achieved, with disparities in diagnostics, particularly in low- and middle-income countries, hindering progress.
Observed on May 8, World Ovarian Cancer Day 2025 carries the theme “No Woman Left Behind,” reinforcing the urgent need to close the gaps in access, diagnosis, treatment, and care across all regions and socioeconomic groups. Ovarian cancer remains one of the deadliest gynecological cancers, often detected too late due to vague symptoms and limited screening tools. The World Ovarian Cancer Coalition projects a 55% rise in annual cases and nearly 70% more deaths by 2050, with the heaviest burden falling on low- and middle-income countries. Equitable access to early diagnostics, genetic testing, and targeted therapies is critical.
In clinics around the world, a concerning pattern is becoming increasingly evident: a growing number of patients are experiencing wheezing, breathlessness, and persistent coughing. This surge reflects a broader global trend. According to the World Health Organization (WHO), more than 260 million people are currently living with asthma, making it one of the most widespread and persistent chronic respiratory conditions globally.
Observed on April 25, World Malaria Day 2025 carries the theme “Accelerating Equity in Malaria Prevention and Cure,” underscoring the urgent need to reach communities still lacking access to life-saving vaccines and diagnostics. While global malaria death rates have seen modest declines, the disease continues to claim the life of one child every minute, highlighting the critical need for swift, equity-driven action
Sulfamethoxazole is a common synthetic antibacterial that is a member of the sulfonamide class of antibiotics. This substance plays a very significant role in modern medicine due to the amazing capabilities offered by the substance for curing infections and bacterial diseases. Trimethoprim and sulfamethoxazole are frequently used together to create the well-known antibiotic co-trimoxazole, which is well-known for its potency against a variety of bacterial infections. It works by preventing the manufacture of folic acid, which is necessary for the growth of bacteria. Sulfamethoxazole is an essential part of modern antibiotic therapy since it has been used to treat lung infections, urinary tract infections, and other common bacterial illnesses.
Healthcare consumables are necessary medical supplies used for patient treatment, diagnostics, and cleanliness in clinics, hospitals, and home care settings. These consist of supplies such as surgical masks, bandages, gloves, syringes, catheters, and disinfectants. Usually, they are disposable or single use to preserve sterility and stop infections. Healthcare consumables are an essential component of the global healthcare ecosystem and are in high demand due to expanding healthcare needs, an increase in operations, infection control measures, and technological improvements.
Catheters are flexible, tubular medical devices designed to access various body cavities, organs, or blood vessels for diagnostic or therapeutic purposes. They can be broadly classified into types based on their application, including urinary catheters, cardiac catheters, and intravenous (IV) catheters. Catheters are commonly used in diverse healthcare settings for managing chronic conditions, enabling fluid drainage, delivering medications, or facilitating minimally invasive surgeries.
Bioinformatics involves applying computational techniques and tools to study and understand biological systems at the molecular level. It is a field of study that combines mathematics, biology, computer science, and statistics to research genomic data and biological networks. The goal is to interpret information from large biological data sets, such as DNA sequences, protein structures, gene expressions, and other high-throughput experimental data. This field provides various products and services, such as knowledge management tools, bioinformatics platforms, and services.
A non-animal model refers to an experimental system or method used in scientific research or testing that does not involve the use of animals. These models are developed to simulate biological processes, test hypotheses, or study diseases without the need for live animals. The aim is often to reduce the reliance on animal testing, which has ethical implications and raises concerns about animal welfare.
Cell therapy involves the transplantation and manipulation of living cells to replace and repair damaged tissue. Its primary branches include stem cell therapy and non-stem cell therapy. Stem cell therapy utilizes stem cells to repair, replace, or rejuvenate damaged or diseased cells and tissues as they possess the ability to differentiate into various specialized cell types, making them valuable for regenerative medicine. Non-stem cell-based therapies typically involve somatic cells isolated from the human body. These cells are propagated, expanded, selected, and then administered to patients for curative, preventive, or diagnostic purposes. On the other hand, gene therapy seeks to treat diseases by introducing, replacing, or inactivating genes within cells.